Signia Introduces Pure Charge&Go BCT IX Hearing Aids Featuring Bluetooth® Classic Connectivity with No Compromise

New Pure Charge&Go BCT IX hearing aids introduce the longest battery runtime of any Bluetooth® Classic hearing aid with an unprecedented 36 hours of battery life. Pure Charge&Go BCT IX is the smallest hearing aid with Bluetooth® Classic available on the market today.[1] Pure Charge&Go BCT IX hearing aids bring the full audiological feature set of the Signia Integrated Xperience (IX) platform to everyone, all day, no matter what phone the wearer wants to connect to. Signia IX, with its RealTime Conversation Enhancement technology, is confirmed to offer more than twice the speech enhancement benefit in noisy group conversations compared to other leading hearing aids.[2] Lynge, Denmark – 24 February 2025 – Hearing aid innovator Signia, the leading hearing aid brand for speech understanding in noisy group conversations and part of WSA, today unveiled another industry first: the longest battery runtime of any Bluetooth® Classic compatible hearing aid—up to 36 hours, including 5 hours of streaming, on a single charge. The new Signia Pure Charge&Go BCT IX also delivers universal device compatibility, pairing quickly and easily with all phones. Designed on the full IX platform, it offers a sleek, super-small design with no compromise on performance. This is Bluetooth® Connectivity Transformed—setting a new standard in Bluetooth® Classic compatible hearing aids. Jens Moeller, Head of Brand Signia, said: Connectivity matters to clients, but it has long been a maze for hearing care professionals. For example, choosing a hearing aid with Bluetooth® Classic often meant compromising on design, battery life, or essential features. The addition of Pure Charge&Go BCT IX to the Integrated Xperience platform is exactly what HCPs and wearers have been waiting for. Finally, a hearing aid with universal device compatibility and no compromises. It’s a solution they can trust to keep them connected, streaming, and enjoying best-in-class hearing assistance all day long. Bluetooth® Connectivity Transformed with no compromise is an engineering feat that incorporates a full-featured, efficient Bluetooth® Classic microchip and proprietary high-density battery into the Pure Charge&Go BCT IX to minimize power consumption and extend battery life without compromising audiological performance or size. Pure Charge&Go BCT IX: Now Everyone Can Connect to the Conversation With Pure Charge&Go BCT IX, wearers get access to the full power of the Signia IX platform, including RealTime Conversation Enhancement, Signia’s breakthrough technology that can track and enhance multiple conversation partners from multiple directions, even if they move, to help wearers hear clearly in group conversations. “This is an absolute game-changer,” Moeller continued. “The combination of Bluetooth® Classic connectivity and RealTime Conversation Enhancement ensures all hearing aid wearers have the confidence to engage, interact, and contribute – especially in noisy group conversations,” Moeller concluded. Introducing the Signia TV Sound Streamer & Insio IX In conjunction with the announcement of the Pure Charge&Go BCT IX, Signia is introducing the new TV Sound Streamer, which connects to the user’s TV and automatically pairs with Pure Charge&Go BCT IX hearing aids. The Signia TV Sound Streamer delivers Dolby-quality stereo sound via Bluetooth® Classic for an immersive audio experience. It is also backward-compatible with all connectivity-enabled Signia devices for streaming that is simple and reliable. Pure Charge&Go BCT IX joins the Pure Charge&Go IX and IX T models, offering HCPs a full range of connectivity options, including Bluetooth® Classic, MFi, LE Audio and ASHA. Whether clients prefer iPhone or Android, there’s a solution within the Pure Charge&Go IX lineup for them. Signia today also introduced the new Insio ITC and ITE IX hearing aids, delivering Integrated Xperience technology at all technology levels. To learn more about Signia Pure Charge&Go BCT IX and Insio IX hearing aids, click here. For the press kit, click here. [1] In a comparison of RIC hearing aids based on the manufacturers’ newest platforms. [2] Jensen NS, Wilson C, Kamkar Parsi H, Samra B, Hain J, Best S & Taylor B. 2024. Signia IX delivers more than twice the speech enhancement benefit in a noisy group conversation than the closest competitors. Signia White Paper. About Signia Signia, a part of WSA, is one of the world’s leading hearing aid brands. We aim to enhance human performance through iconic innovations and consumer-friendly designs that shape the hearing health market. Since its launch in 2016, Signia has regularly brought innovative, industry-leading solutions to the market and is a pioneer in rechargeable hearing technology. In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management. Signia, and its hearing care professionals, enable hearing aid wearers not just to correct hearing loss but to gain an edge — to Be Brilliant.
Subscribe to releases from WS Audiology
Subscribe to all the latest releases from WS Audiology by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from WS Audiology
Carsten Buhl to leave WSA10.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 10, 2025 – WSA, a leading pure-play hearing healthcare group, today announced that Carsten Buhl, member of the Executive Committee and Executive Board of WSA, and President of its Americas Region, has decided to pursue a new career outside WSA and to leave the company on August 31, 2025. Carsten Buhl joined WSA in 2019, where he first served as President of the EMEA-LATAM-Canada region, next to being a member of WSA’s Group Management Team. In 2022 he was appointed President of the Americas Region. WSA CEO Jan Makela commented: We are sorry to see Carsten go and will certainly miss his constructive leadership style, as well as his deep insights into the hearing care market. We are happy for him as we part ways on positive terms. We are grateful for his many contributions to our company, and we wish him every success! Carsten Buhl said: “I am proud of my journey at WSA and what we have achieved together working with a fantastic group of highly motivated colleagues.
Dorothea Wenzel joins WSA’s Board of Directors and is appointed Chair of the Audit Committee2.6.2025 00:00:00 CEST | Press release
Lynge, Denmark, June 2, 2025 – WSA, a leading pure-play hearing healthcare group, is pleased to announce that Dorothea Wenzel has joined its Board of Directors and has been appointed Chair of the Audit Committee, effective immediately. At the same time, Julian Tøpholm is stepping down from the Board. Ms. Wenzel joins as an independent director with an impressive track record in finance and strategy leadership across multiple industries, including a long career at the biopharmaceutical company Merck, where she held several commercial and financial executive positions. She has extensive experience in leading business transformations, and significant board experience from Dentsply Sirona Inc., Servier Group, Gerresheimer, and as Lead Independent Director at Fresenius Medical Care AG & Co. Most recently, she was appointed Chair of Lundbeck, following her tenure as Chair of its Audit Committee. WSA Chair Lars Rasmussen commented: We are delighted to welcome Dorothea to the WSA Board. Her br
WSA delivered 1% organic revenue growth and increased EBITDA by 22% in the second quarter of FY 2024/258.5.2025 00:00:00 CEST | Press release
Lynge, Denmark – May 8, 2025 – WSA, a leading pure-play hearing healthcare group, today announced results for the second quarter of the financial year 2024/25 (January 1, 2025 – March 31, 2025) showing organic revenue growth of 1% and an increase in EBITDA of 22%, corresponding to an EBITDA margin improvement of 2.8%-points. Jan Mäkelä, CEO of WSA, said: With an organic revenue growth of 1% in a volatile macro environment and a significant EBITDA margin improvement, WSA delivered satisfactory second quarter results. I am very pleased with the successful launch of Signia BCT IX and Widex Allure at the end of the quarter. With our complementary and distinct Signia and Widex brand platforms, we are committed to delivering an uncompromising hearing experience that meets the unique needs of the largest groups of people with hearing loss and the hearing care professionals serving them.” Highlights Q2 2024/2025 (Q2 last financial year in brackets) WSA delivered organic revenue growth of 1% (7
WS Audiology Expands Indian Operations with New Commercial and Production Hub in Bangalore16.4.2025 00:00:00 CEST | Press release
Bangalore, India – 16 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced the opening of its new office in Bangalore, further strengthening its footprint in India. The facility, operating as WS Audiology India, will serve as a key hub for commercial and production activities, supporting WSA’s long-term commitment to improve hearing health access across the country. The new Bangalore office reflects WSA’s belief in India’s growing role in the global hearing care landscape. According to the World Health Organization, an estimated 6.3% of India’s population suffers from significant hearing loss. WSA continues to lead the industry in making hearing care more accessible, affordable, and effective through its “Triple A” approach—Awareness, Affordability, and Accessibility. Supporting Growth, Enhancing Service “India has been one of our fastest-growing markets in APAC, and we’re incredibly proud of the work our teams have done here,” said Avinash Pa
WSA welcomes ATHOS KG as a new shareholder and receives new investment to support its long-term development11.4.2025 00:00:00 CEST | Press release
Lynge, Denmark – 11 April 2025 – WS Audiology (WSA), a leading pure play hearing health care group, today announced ATHOS KG as a new minority shareholder, as well as an equity capital injection of EUR c. 590 million in total from its existing and new shareholders to further support the company’s successful growth trajectory and long-term strategic ambitions. WSA welcomes ATHOS, a German healthcare focused single family office, as a new shareholder alongside T&W Medical, EQT, and the Lundbeck Foundation, which together continue to exercise joint control of WSA in an unchanged governance set-up. Lars Rasmussen, Chair of WSA, said: I am pleased by the strong commitment of WSA’s shareholders to the company’s continued growth and long-term development. The owners have decided to strengthen WSA’s financial foundation by injecting equity, which will further bring down WSA’s net leverage. At the same time, I am pleased to welcome ATHOS as a shareholder of WSA. With T&W Medical, EQT, the Lundb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom